(Q37973536)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Pulmonary hypertension: Hemodynamic evaluation. Updated Recommendations of the Cologne Consensus Conference 2011 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

main subject

arterial hypertension

0 references

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

12

Dirk Skowasch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Christian F Opitz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Rüdiger Blindt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Friedrich Blumberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mathias M Borst

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Leonhard Bruch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Hanno H Leuchte

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Christian Nagel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Klaus Peters

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Stephan Rosenkranz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Dietmar Schranz

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Henning Tiede

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Joachim Weil

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ralf Ewert

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

1 reference

1 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cardiology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

154 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

S13-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Guidelines for the diagnosis and treatment of pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Diagnostik und Therapie der pulmonalen Hypertonie: Europäische Leitlinien 2009

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Pulmonary arterial hypertension in France: results from a national registry

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

An epidemiological study of pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Mechanisms of improved arterial oxygenation after peripheral chemoreceptor stimulation during hypoxic exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Role of pharmacologic tests in the treatment of primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Adenosine for vasoreactivity testing in pulmonary hypertension: a head-to-head comparison with inhaled nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Long-term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Survival with first-line bosentan in patients with primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Pulmonary artery pressure-flow relations after prostacyclin in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Hemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Pulmonary vasoreactivity and vasoactive mediators in children with pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Evaluation of pulmonary hypertension in heart transplant candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

First experiences with the stable prostacyclin analog iloprost in the evaluation of heart transplant candidates with increased pulmonary vascular resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2811%2970489-2

7 January 2021

10.1016/S0167-5273(11)70489-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22221969%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference